SPEARHEAD-1: A phase II trial of ADP-A2M4 SPEAR T cells in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma.

Araujo, DM; Druta, M; Agulnik, M; D'Angelo, SP; Blay, JY; Strauss, SJ; Valverde, C; Razak, ARA; Van Winkle, E; Trivedi, T; Biswas, S; Williams, D; Norry, E

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):